Lunaphore is a Swiss firm born with the vision of bringing –omics like approaches to in-situ tissue analytics for cancer research and diagnostic purposes.
Lunaphore develops innovative tissue staining platforms based on a cutting-edge technology, providing high quality results much faster than current techniques and aiming to automate some of the most sophisticated assays thanks to high-precision fluidics. We further enable digital pathology through the integration of imaging systems such as a microscope with sequential data extraction. Lunaphore has been repeatedly recognized for its innovation.
